Have a personal or library account? Click to login
Istradefylline for Restless Legs Syndrome Associated with Parkinson’s Disease Cover

Istradefylline for Restless Legs Syndrome Associated with Parkinson’s Disease

Tremor and Other Hyperkinetic Movements
Volume 8 (2018): Issue 0
By: Maierdanjiang Nuermaimaiti,  Genko Oyama,  Chayut Kasemsuk and  Nobutaka Hattori  
Open Access
|Jan 2018

Figures & Tables

Table 1

Patient Characteristics of the Three Presented Cases

Case 1Case 2Case 3
Age/sex73/M65/M52/M
Parkinson’s disease duration (years)12115
Dosage of istradefylline20 mg40 mg20 mg
L-dopa+++
Dopamine agonist+++
Follow-up30 months5 months17 months
Augmentation–––
DOI: https://doi.org/10.5334/tohm.429 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Oct 16, 2017
Accepted on: Dec 14, 2017
Published on: Jan 8, 2018
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Parkinsonism,
restless legs syndrome,
adenosine A2A receptor

© 2018 Maierdanjiang Nuermaimaiti, Genko Oyama, Chayut Kasemsuk, Nobutaka Hattori, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.

Previous articleVolume 8 (2018): Issue 0Next article